Marcadia Biotech, Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Marcadia Biotech, Inc.
Indonesia and its state-owned PT Kimia Farma are moving to make the nation independent of imported versions of HIV/AIDS drugs.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Venture Funding column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced October through November 2013.
A review of deal-making in the diabetes space since 2010 finds deals around technology to regenerate pancreatic beta cells and/or islet cells as the hottest mechanism of action. Thirteen deals in this area out-number the combined deals involving the DPP-4, SGLT-2 and GLP-1 mechanisms during that period.
Univfy Inc. has developed evidence-based, personalized prediction models of in vitro fertilization treatment success for fertility patients and their health care providers, as a support tool to help increase the success of IVF, decrease dropout rates, and better assess the risks of the procedure.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.